Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism

Authors:
Sébastien Levesque , Andrea Cosentino,  Archana Verma , Pietro Genovese , Daniel E Bauer 
In:
Source: Nat Biotechnol
Publication Date: (2024)
Issue: :
Research Area:
Immunotherapy / Hematology
Stem Cells
Cells used in publication:
K-562
Species: human
Tissue Origin: blood
Jurkat
Species: human
Tissue Origin: blood
CD34+ cell, human
Species: human
Tissue Origin: blood
Culture Media:
Platform:
4D-Nucleofector® X-Unit
Experiment

For standard conditions, CD34+ HSPCs were thawed and cultured for 24 h in the presence of cytokines before nucleofection. CD34+ HSPCs were electroporated using the P3 Primary Cell 4D-Nucleofector X Kit S(Lonza, catalog no. V4XP-3032) according to the manufacturer’s recommendations. Unless otherwise indicated, 2.5 × 105 cells were electroporated with 2,000 ng prime editor mRNA, 200 pmol (e)pegRNA and 100 pmol nicking sgRNA using pulse code DS-130. For TwinPE conditions, 2.5 × 105 cells were electroporated with 2,000 ng PEmax mRNA and 150 pmol of each (e)pegRNA using pulse code DS-130. For Vpx mRNA co-delivery, Vpx:PEmax mRNAs were electroporated at an equimolar ratio.

K562 cells (2 × 105 cells) were electroporated with 750 ng PEmax vector, 250 ng epegRNA vector and 100 ng nicking sgRNA vector using the SF Cell Line 4D-Nucleofector X Kit S (Lonza, catalog no. V4XC-2032) and pulse code FF-120. Jurkat cells (5 × 105 cells) were electroporated with 500 ng PEmax vector, 250 ng epegRNA vector and 100 ng nicking sgRNA vector using the SE Cell Line 4D-Nucleofector X Kit S (Lonza, catalog no. V4XC-1032) and pulse code CL-120. K562 and Jurkat cells
were cultured for 72 h before genotyping.

Abstract

Therapeutic prime editing of hematopoietic stem and progenitor cells (HSPCs) holds great potential to remedy blood disorders. Quiescent cells have low nucleotide levels and resist retroviral infection, and it is possible that nucleotide metabolism could limit reverse transcription-mediated prime editing in HSPCs. We demonstrate that deoxynucleoside supplementation and Vpx-mediated degradation of SAMHD1 improve prime editing efficiency in HSPCs, especially when coupled with editing approaches that evade mismatch repair.